Akutes Auftreten einer eosinophilen Dermatitis nach COVID-19-Impfung mit BNT162b2 (Comirnaty)

被引：0
|
作者：
Kabatas, A. S. [1 ]
Gaetjen, F. [1 ]
Schacht, V. [1 ]
Kapp, A. [1 ]
Wedi, B. [1 ]
机构：
[1] Hannover Med Sch, Klin fur Dermatologie, Allergologie und Venerologie der, Hannover, Germany
来源：
ALLERGOLOGIE | 2023年 / 46卷 / 02期
关键词：
COVID-19; vaccination; dermatitis; eosinophilic; granulocytes;
D O I：
10.5414/ALX02356
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
In the current time, the question about possible side effects of the COVID-19 immunization has a high priority, especially because booster vaccinations are being discussed, making the occurrence of side effects more likely. In order to better understand the latter, the compilation of the side effects that have occurred is indispensable. Therefore, we report a new case from our dermatological university outpatient clinic at Hannover Medical School, which sheds light on a possible link between active immunization to prevent COVID-19 disease caused by SARS-CoV-2 and the role of eosinophilic granulocytes.
引用
收藏
页码：107 / 112
页数：6
相关论文
共 50 条
  • [41] Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents
    Mansanguan, Suyanee
    Charunwatthana, Prakaykaew
    Piyaphanee, Watcharapong
    Dechkhajorn, Wilanee
    Poolcharoen, Akkapon
    Mansanguan, Chayasin
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2022, 7 (08)
  • [42] Unusual lymphadenopathies secondary to the BNT162b2 mRNA Covid-19 vaccine
    Manuel Felices-Farias, Jose
    Francisco Martinez-Martinez, Juan
    Guzman-Aroca, Florentina
    MEDICINA CLINICA, 2022, 158 (07): : 343 - 344
  • [43] Mucosal immune response in BNT162b2 COVID-19 vaccine recipients
    Azzi, Lorenzo
    Dalla Gasperina, Daniela
    Veronesi, Giovanni
    Shallak, Mariam
    Ietto, Giuseppe
    Iovino, Domenico
    Baj, Andreina
    Gianfagna, Francesco
    Maurino, Vittorio
    Focosi, Daniele
    Maggi, Fabrizio
    Ferrario, Marco Mario
    Dentali, Francesco
    Carcano, Giulio
    Tagliabue, Angelo
    Maffioli, Lorenzo Stefano
    Accolla, Roberto Sergio
    Forlani, Greta
    EBIOMEDICINE, 2022, 75
  • [44] Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adults
    Priddy, Frances H.
    Williams, Michael
    Carson, Simon
    Lavender, Brittany
    Mathieson, Julia
    Frampton, Chris
    Moreland, Nicole J.
    McGregor, Reuben
    Williams, Georgia
    Brewerton, Maia
    Gell, Katie
    Ussher, James
    Le Gros, Graham
    VACCINE, 2022, 40 (34) : 5050 - 5059
  • [45] Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents
    Olson, S. M.
    Newhams, M. M.
    Halasa, N. B.
    Price, A. M.
    Boom, J. A.
    Sahni, L. C.
    Pannaraj, P. S.
    Irby, K.
    Walker, T. C.
    Schwartz, S. P.
    Maddux, A. B.
    Mack, E. H.
    Bradford, T. T.
    Schuster, J. E.
    Nofziger, R. A.
    Cameron, M. A.
    Chiotos, K.
    Cullimore, M. L.
    Gertz, S. J.
    Levy, E. R.
    Kong, M.
    Cvijanovich, N. Z.
    Staat, M. A.
    Kamidani, S.
    Chatani, B. M.
    Bhumbra, S. S.
    Bline, K. E.
    Gaspers, M. G.
    Hobbs, C., V
    Heidemann, S. M.
    Maamari, M.
    Flori, H. R.
    Hume, J. R.
    Zinter, M. S.
    Michelson, K. N.
    Zambrano, L. D.
    Campbell, A. P.
    Patel, M. M.
    Randolph, G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (08): : 713 - 723
  • [46] Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine
    Moreira, Edson D., Jr.
    Kitchin, Nicholas
    Xu, Xia
    Dychter, Samuel S.
    Lockhart, Stephen
    Gurtman, Alejandra
    Perez, John L.
    Zerbini, Cristiano
    Dever, Michael E.
    Jennings, Timothy W.
    Brandon, Donald M.
    Cannon, Kevin D.
    Koren, Michael J.
    Denham, Douglas S.
    Berhe, Mezgebe
    Fitz-Patrick, David
    Hammitt, Laura L.
    Klein, Nicola P.
    Nell, Haylene
    Keep, Georgina
    Wang, Xingbin
    Koury, Kenneth
    Swanson, Kena A.
    Cooper, David
    Lu, Claire
    Tuereci, Oezlem
    Lagkadinou, Eleni
    Tresnan, Dina B.
    Dormitzer, Philip R.
    Sahin, Ugur
    Gruber, William C.
    Jansen, Kathrin U.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (20): : 1910 - 1921
  • [47] Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
    Barda, Noam
    Dagan, Noa
    Ben-Shlomo, Yatir
    Kepten, Eldad
    Waxman, Jacob
    Ohana, Reut
    Hernan, Miguel A.
    Lipsitch, Marc
    Kohane, Isaac
    Netzer, Doron
    Reis, Ben Y.
    Balicer, Ran D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (12): : 1078 - 1090
  • [48] Eosinophilic cellulitis after BNT162b2 mRNA Covid-19 vaccine
    de Montjoye, L.
    Marot, L.
    Baeck, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (01) : E26 - E28
  • [49] Evaluation of lung immune response to the BNT162b2 COVID-19 vaccine
    Padawer, D.
    Stolovich-Rain, M.
    Billan, M.
    Berkman, N.
    Rouvinski, A.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [50] Recurrent Aseptic Meningoencephalitis Following BNT162b2 Vaccination for COVID-19
    Kang, Kyusik
    Lee, Jung-Ju
    Kim, Byung-Kun
    JOURNAL OF CLINICAL NEUROLOGY, 2022, 18 (06): : 723 - 725
12345